IP Library Granted Patent US 11,795,578
Granted Patent B2
US 11,795,578 · App. 17/728,093 · Granted Oct 24, 2023

Methods of analyzing nucleic acids

Inventors: Scott Kuersten (Madison, WI); Agnes Radek (Madison, WI); Ramesh Vaidyanathan (Madison, WI); Haiying Li Grunenwald (Madison, WI)
Assignee: Illumina, Inc.
C40B30/04C12N15/1096C12Q1/6806C12Q1/6874
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,795,578
App. No.
17/728,093
Granted
Oct 24, 2023
Kind
B2
Abstract

Presented herein are methods and compositions for analyzing rare nucleic acid species. Some methods presented herein use DNA reassociation kinetics following thermal denaturation to define populations of nucleic acid sequences, e.g., highly abundant (e.g., cDNA from rRNA), moderately abundant, and less abundant or rare sequences (e.g., cDNA from mRNA).

Claims (27)

1. A method of analyzing rare nucleic acid species comprising:

(a) providing a library of double-stranded nucleic acids;

(b) denaturing the library;

(c) renaturing the library under conditions sufficient to renature abundant nucleic acid species, wherein a portion of the library comprising less abundant nucleic acid species does not renature;

(d) contacting the library with a nucleic acid binding protein that preferentially binds to single-stranded nucleic acids; and

(e) separating renatured abundant nucleic acid species from the less abundant nucleic acid species.

2. The method of claim 1 , wherein separating comprises immobilizing the nucleic acid binding protein to a solid support.

3. The method of claim 1 , wherein denaturing comprises heat denaturing.

4. The method of claim 3 , wherein heat denaturing comprises application of heat above 70° C., 75° C., 80° C., 85° C., 90° C., 91° C., 92° C., 93° C., 94° C., or above 95° C.

5. The method of claim 1 , wherein renaturing comprises lowering the denaturation temperature to a temperature of about 40° C. to about 65° C. for a sufficient period of time to renature abundant nucleic acid species.

6. The method of claim 5 , wherein the sufficient period of time comprises about 30 minutes to about 24 hours.

7. The method of claim 1 , wherein denaturing comprises chemical denaturing.

8. The method of claim 1 , further comprising sequencing the separated less abundant nucleic acid species.

9. The method of claim 1 , wherein the library comprises genomic DNA.

10. The method of claim 1 , wherein the library comprises randomly sheared DNA.

11. The method of claim 1 , wherein the library comprises double-stranded cDNA.

12. The method of claim 1 , wherein the nucleic acids in the library comprise adaptor sequences ligated to the ends of the nucleic acids.

13. The method of claim 12 , wherein the adaptor sequences comprise one or more of: amplification priming binding region, sequencing primer binding region, and promotor sequences for in vitro transcription.

14. The method of claim 1 , wherein the abundant nucleic acid species comprise highly repetitive sequences.

15. The method of claim 1 , wherein the library comprises nucleic acid from a single cell or a small group of cells.

16. The method of claim 1 , wherein the abundant nucleic acid species comprise host sequences and the less abundant nucleic acid species comprise pathogen content.

17. The method of claim 1 , wherein the abundant nucleic acid species comprise duplicate libraries in a sequencing library.

18. The method of claim 1 , wherein the library comprises genomic RNA.

19. The method of claim 1 , wherein the nucleic acid binding protein is immobilized on a solid support prior to the separating.

20. The method of claim 1 , wherein the single-stranded nucleic acids are DNA.

21. The method of claim 1 , wherein the nucleic acid binding protein comprises an affinity binding molecule.

22. The method of claim 21 , wherein the affinity binding molecule comprises biotin or streptavidin.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2022
From: KUERSTEN, SCOTT; RADEK, AGNES; VAIDYANATHAN, RAMESH; GRUNENWALD, HAIYING LI
To: EPICENTRE TECHNOLOGIES CORPORATION
Reel/Frame 059998/0434 →
MERGER Recorded May 24, 2022
From: EPICENTRE TECHNOLOGIES CORPORATION
To: ILLUMINA, INC.
Reel/Frame 059998/0577 →